BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
BRN - BRAINCHIP HOLDINGS LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Index: ASX300 | ALL-ORDS | ALL-TECH
FNArena Sector : Medical Equipment & Devices
Year End: June
Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.47
15 Sep |
OPEN $0.48 |
HIGH $0.49 |
6,421,776 LOW $0.47 |
-0.010| OTHER COMPANIES IN THE SAME SECTOR | |||
| ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . PME . CSX . 4DX . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . AT1 . CBL . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
| Title | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -2.6 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 0.2 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 1.4 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -14.6 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -22,198.35 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -167.37 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -216.96 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -71.53 % |
| Capex | xxx | xxx | xxx | xxx | xxx | 0.1 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 36.61 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -14.6 M |
Return on Assets
Return on Equity
Return on Total Capital
Capex
Capex % of Sales
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
BRN STOCK CHART
FNArena News on BRN
| 1 |
June In Review: FY21 Closes With Eleventh Monthly GainJul 07 2021 - Australia |
| 2 |
RESEARCH: Weebit Nano Valuation Update $4.75 Per ShareJan 15 2021 - FYI |
| 3 |
Metals X Firing On Copper And TinMar 27 2017 - Small Caps |
Latest Medical Equipment & Devices News
| 1 |
Nanosonics Unveils Its New ProductAug 26 2021 - Australia |
| 2 |
Pro Medicus: Opportunity AwaitsAug 24 2021 - Technicals |
| 3 |
Breakout For CochlearAug 10 2021 - Technicals |
| 4 |
Will ResMed’s Market Share Gains Last?Aug 09 2021 - Australia |
| 5 |
Treasure Chest: Has Nanosonics Been Too Successful?Jul 08 2021 - Treasure Chest |
| 6 |
Opportunity For ResMed Following Philips RecallJun 16 2021 - Australia |
| 7 |
Treasure Chest: How Much Covid Impact For Nanosonics?May 13 2021 - Treasure Chest |
| 8 |
Who Will Be The Next Pro Medicus?May 13 2021 - Weekly Reports |
| 9 |
New Product, Patient Growth Key To ResMedMay 03 2021 - Australia |
| 10 |
Growth For ResMed Despite ChallengesFeb 01 2021 - Australia |